IMV Inc.

  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific & Clinical Advisors
  • Careers
    • Overview
    • Life at IMV
  • The DPX™ Platform
    • Overview
    • Scientific Publications & Posters
  • Clinical Pipeline
    • Overview
    • Maveropepimut-S
    • DPX-RSV
    • DPX-COVID-19
    • Clinical Trials
  • News & Events
    • Press Releases
    • Events
    • Email Alerts
  • Investors
    • Overview
    • Press Releases
    • Events, Webcasts & Presentations
    • Financial Info
    • Stock Data
    • Filings
    • Governance
    • Contact Us
    • FAQ
  • Contact

Press Releases

News & Events

News & Events

  • Press Releases
  • Events
  • Email Alerts
Apr 11, 2011 9:17am EDT

Immunovaccine Reports Positive Interim Data from Phase I Clinical Trial of DPX-0907 in Patients With Breast, Ovarian and Prostate Cancer

Apr 05, 2011 9:08am EDT

Immunovaccine Presents at Two International Scientific Conferences

Apr 01, 2011 6:00pm EDT

Immunovaccine Announces Issuance of Common Shares to a Consultant

Mar 21, 2011 9:05am EDT

Immunovaccine Receives $2.9M from ACOA

Mar 02, 2011 5:30pm EST

Immunovaccine Announces Issuance of Common Shares to a Consultant

Feb 23, 2011 8:55am EST

Immunotope and Immunovaccine Announce U.S. Patent for Therapeutic Cancer Vaccine Antigens

Feb 10, 2011 8:31am EST

Immunovaccine Provides Corporate Update

Feb 02, 2011 5:30pm EST

Immunovaccine Announces Issuance of Common Shares to a Consultant

Jan 05, 2011 8:56am EST

Immunovaccine to Present at Biotech Showcase(TM) 2011

Jan 04, 2011 5:30pm EST

Immunovaccine Announces Issuance of Common Shares to a Consultant

RSS
  • Prev
  • 1...
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • Next
IMV Inc.
About Us Careers The DPX™ Platform Clinical Pipeline News & Events Investors Contact
Twitter LinkedIn Youtube
© 2022 IMV Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap